Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GI05-92

A Pilot Study With Cetuximab and Radiation Therapy for Patients With Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group Study (GI05-92)

ClinicalTrials.gov Identifier: NCT00319735.

Abstracts/Posters/Presentations:

  • M. M. Sgroi, N. Hanna, A. McCollum, N. Bechar, M. DiMaio, Z. Hammoud, M. Yu, H. Choy, C. Beccera. Pre-Operative Cetuximab and Radiation (XRT) for Patients (pts) with Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas: A Pilot Study from the Hoosier Oncology Group and the University of Texas-Southwestern: GI05-92. Accepted to the general poster session at the ASCO Annual Meeting, May 30-June 3, 2008, Chicago, IL
  • A.K. Agarwala, N. Hanna, A. McCollum, N. Bechar, M. DiMaio, M. Yu, Y. Tong, C.R. Beccera, H.Choy. Pre-operative Cetuximab and Radiation (XRT) for Patients (pts) with Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas: A Pilot Study from the Hoosier Oncology Group (HOG) and the University of Texas-Southwestern: GI05-92. Accepted to the general poster session at the ASCO annual meeting May 29-June 2, 2009, Orlando, FL J Clin Oncol 27:15s, 2009 (suppl; abstr 4557)

Manuscripts/Articles:

  • Becerra CR, Hanna N, McCollum AD, Becharm N, Timmerman RD, Dimaio M, Kesler KA, Yu M, Yan T, Choy H. A Phase II Study with Cetuximab and Radiation Therapy for Patients with Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group GI05-92. J Thorac Oncol. 2013 Sep 30. [Epub ahead of print] PMID: 24084441
  • Beccera C, Hanna N, McCollum A, Bechar N, Timmerman R, DiMaio M, Kesler K, Yu M, Yan T, Choy H. A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GEJ junction carcinomas: Hoosier Oncology Group GI05-92. J Thorac Oncol 2013 Nov;8(11):1425-9. doi: 10.1097/JTO.0b013e3182a46c3b